title: Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
authors.affiliation: Institute of Cardiovascular Diseases, Bologna, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Boriani
authors.forename: M
authors.initials: M
authors.lastname: Biffi
authors.forename: L
authors.initials: L
authors.lastname: Frabetti
authors.forename: U
authors.initials: U
authors.lastname: Azzolini
authors.forename: P
authors.initials: P
authors.lastname: Sabbatani
authors.forename: G
authors.initials: G
authors.lastname: Bronzetti
authors.forename: A
authors.initials: A
authors.lastname: Capucci
authors.forename: B
authors.initials: B
authors.lastname: Magnani
mesh_terms: D000328:Adult; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D014693:Ventricular Fibrillation / Q000139:chemically induced*; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications / Q000188:drug therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone